Influence of ganglioside combined with methylprednisolone sodium succinate on efficacy and neurological function in patients with acute myelitis

Table 1 General data, n (%) or mean ± SEM

Factors	Control group (n = 52)	Observation group (n = 56)	χ2/t	P value
Age (yr)	43.85 ± 8.23	42.98 ± 8.30	0.546	0.586
Sex (male/female)	28/24	33/23	0.283	0.595
Time of onset (d)	3.06 ± 0.46	3.20 ± 0.62	1.324	0.188
Lower limb muscle strength (grade 0-1/grade 2-3)	26/26	30/26	0.138	0.711
Marital status (married/single)	35/17	29/27	2.691	0.101

Table 2 Therapeutic effect, n (%)

Factors	Control group (n = 52)	Observation group (n = 56)	χ2	P value
Cured	17 (32.69)	24 (42.86)	-	-
Marked response	14 (26.92)	20 (35.71)	-	-
Response	7 (13.46)	6 (10.71)	-	-
Nonresponse	14 (26.92)	6 (10.71)	-	-
Total	38 (73.08)	50 (89.29)	4.695	0.030

Table 3 Occurrence of adverse events, n (%)

Factors	Control group (n = 52)	Observation group (n = 56)	χ2	P value
Rash	2 (3.85)	1 (1.79)	-	-
Gastrointestinal discomfort	2 (3.85)	1 (1.79)	-	-
Dyslipidemia	4 (7.69)	2 (3.57)	-	-
Osteoporosis	3 (5.77)	0 (0.00)	-	-
Total	11 (21.15)	4 (7.14)	4.426	0.035